These increases in SLC2A1 (Fig. 4A, 4C) and CAIX (Fig. 4B, 4D) in the V.C./EtOH group could potentially be employed to detect the early stages of ESCC. This evidence concerns the gene CA9 and esophageal squamous cell carcinoma.